Point72 Middle East Fze Vertex Pharmaceuticals Inc Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $2.2 Million - $2.63 Million	6,400 Added 2133.33%	6,700 $2.73 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $135,272 - $144,984	-400 Reduced 57.14%	300 $104,000
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $31,442 - $35,191	-100 Reduced 12.5%	700 $246,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $28,323 - $32,310	-100 Reduced 11.11%	800 $252,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $257,184 - $289,332	900 New	900 $0

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.